Amgen launches $4 bln debt sale in 3 parts-mkt source

(Reuters) - Morgan Stanley and Merrill Lynch are managing the sale,
which will be used to fund a $3 billion share repurchase by
Amgen.




Read more at Reuters.com Bonds News